The New York City Walk with Us to Cure Lupus is the Lupus Research Alliance (LRA)'s signature national fundraising program, designed to increase awareness of lupus and raise crucial funds for lupus ...
The cause of lupus has long escaped doctors trying to treat the autoimmune disease. However, a study published this week identified a cause of lupus based on molecular defects in patients' blood.
Melatonin, the sleep hormone may help manage lupus by reducing inflammation and oxidative stress, with benefits for lupus ...
In a new study, researchers examined the Renal Activity Index for Lupus (RAIL) diagnostic tool to assess its success for identification and prediction of active lupus nephritis treatment response in ...
The saying: “Lightning does not strike the same place twice” does not apply to 23-year-old Michelle Irara. She was recovering from surgery to remove swelling from her spinal cord that left her ...
EAST RUTHERFORD, N.J., May 1, 2024 /PRNewswire/ -- Nearly 1,500 supporters will help tackle lupus this Saturday, May 4, for the Lupus Research Alliance (LRA) 2024 New Jersey Walk with Us to Cure Lupus ...
Pharmaceutical Technology on MSN
EC approves Roche’s Gazyva to treat active lupus nephritis
Roche has received approval from the European Commission (EC) for its humanised monoclonal antibody Gazyva/Gazyvaro (obinutuzumab) along with mycophenolate mofetil (MMF), for adults with active Class ...
All marathoners have their own particular motivations for running a 26.2-mile race — and for Molly Anderson, Sarah Edwards and Laura Haley, it was to honor Rosie De Queljoe Herzog, their longtime ...
NEW YORK-- There was a walk on the West Side for a good cause Saturday. It was a sea of purple as some 2,000 people took part in the Walk to Cure Lupus at the Intrepid on Pier 86. Many walked in ...
Imagine your body attacking itself. That’s what happens with lupus, a chronic autoimmune disease affecting millions worldwide. Lupus Alert Day is a chance to shine a spotlight on this condition. It’s ...
GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results